AD

Financial statements Maxxgroup

Balance sheet of Maxxgroup

Company age:
Age:
11 y. 9 m. 29 d.
Share capital:
Share capital:
100 000 PLN

Balance sheet data of MAXXGROUP

Year
2018
2019
2020
2021
2022
2023
2024
2025
Total assets 428 308,52 14 847,35 5 375 355,51 8 075 429,18 8 865 469,01 5 043 150,93 5 494 810,42 4 578 000,40
A. Fixed assets 10 000,00 10 000,00 5 360 000,00 8 030 650,38 8 403 473,50 4 328 672,38 1 792 148,32 1 880 024,57
B. Current assets 418 308,52 4 847,35 15 355,51 44 778,80 461 995,51 714 478,55 3 702 662,10 2 697 975,83
C. Share capital contributions (basic funds) - - 0,00 0,00 0,00 0,00 - -
D. Own shares (stocks) - - 0,00 0,00 0,00 0,00 - -
Total liabilities 428 308,52 14 847,35 5 375 355,51 8 075 429,18 8 865 469,01 5 043 150,93 5 494 810,42 4 578 000,40
A. Equity 422 260,52 11 075,35 13 715,51 252 311,18 254 817,38 551 356,44 80 384,86 -110 420,80
B. Liabilities and provisions for liabilities 6 048,00 3 772,00 5 361 640,00 7 823 118,00 8 610 651,63 4 491 794,49 5 414 425,56 4 688 421,20
I. Long-term liabilities - - 5 350 000,00 7 815 000,00 8 161 750,00 0,00 3 822 287,00 3 336 484,00
II. Short-term liabilities 6 048,00 3 772,00 11 640,00 8 118,00 36 703,65 4 079 596,51 1 472 902,93 1 351 937,20
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD